RELATED CONTENT
NEWS
- Alliance Boots explores collaboration with Nanjing Pharma to bolster Chinese presence
- Genzyme and ISIS submit first filing for mipomersenin EU to treat FH
- Generics firms urge EC to help boost sales in EU and emerging markets
- Zydus sets sight on US controlled substances market via Nesher buy

